OS Therapies Statistics
Total Valuation
OS Therapies has a market cap or net worth of $83.73 million. The enterprise value is $84.16 million.
Important Dates
The next estimated earnings date is Monday, August 17, 2026, after market close.
| Earnings Date | Aug 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OS Therapies has 44.54 million shares outstanding. The number of shares has increased by 212.22% in one year.
| Current Share Class | 44.54M |
| Shares Outstanding | 44.54M |
| Shares Change (YoY) | +212.22% |
| Shares Change (QoQ) | +11.00% |
| Owned by Insiders (%) | 12.42% |
| Owned by Institutions (%) | 6.53% |
| Float | 36.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 1.92 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.05
| Current Ratio | 0.05 |
| Quick Ratio | 0.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -449.59 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -366.63% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 350.90% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$7.05M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.82% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +6.82% |
| 50-Day Moving Average | 1.73 |
| 200-Day Moving Average | 1.67 |
| Relative Strength Index (RSI) | 56.29 |
| Average Volume (20 Days) | 667,503 |
Short Selling Information
The latest short interest is 2.03 million, so 4.56% of the outstanding shares have been sold short.
| Short Interest | 2.03M |
| Short Previous Month | 1.32M |
| Short % of Shares Out | 4.56% |
| Short % of Float | 5.61% |
| Short Ratio (days to cover) | 2.79 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -33.87M |
| Pretax Income | -35.27M |
| Net Income | -35.27M |
| EBITDA | -33.39M |
| EBIT | -33.87M |
| Earnings Per Share (EPS) | -$1.05 |
Full Income StatementBalance Sheet
The company has $917,552 in cash and $1.34 million in debt, giving a net cash position of -$425,390 or -$0.01 per share.
| Cash & Cash Equivalents | 917,552 |
| Total Debt | 1.34M |
| Net Cash | -425,390 |
| Net Cash Per Share | -$0.01 |
| Equity (Book Value) | -9.75M |
| Book Value Per Share | -0.28 |
| Working Capital | -16.04M |
Full Balance SheetCash Flow
| Operating Cash Flow | -15.36M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 487,328 |
| Net Borrowing | 1.84M |
| Free Cash Flow | -15.36M |
| FCF Per Share | -$0.34 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |